Wake Forest University Health Sciences
Clinical trials sponsored by Wake Forest University Health Sciences, explained in plain language.
-
Spine cancer combo therapy trial ends early after just one patient
Disease control TerminatedThis early-stage study tested combining targeted spine radiation with the immunotherapy drug pembrolizumab in people with advanced spinal tumors pressing on the spinal cord. Only one person enrolled before the study was stopped early. The goal was to see if this treatment approac…
Phase: EARLY_PHASE1 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New wound closure method tested in High-Risk surgery patients
Disease control TerminatedThis study looked at a new way to close surgical wounds in women at high risk for complications after gynecologic abdominal surgery. Instead of leaving the wound partially open to heal, the new method closes it partially right after surgery and fully closes it a few days later. T…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC
-
Liver cancer study halted after just 2 patients
Disease control TerminatedThis study aimed to see if adding electromagnetic fields to the drug regorafenib could help people with advanced liver cancer live longer without their cancer growing. It was designed for patients who had already tried other treatments. However, the study was stopped early after …
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Early trial combines two chemo drugs with radiation for aggressive sarcomas
Disease control TerminatedThis Phase 1 trial tested a combination of two chemotherapy drugs (gemcitabine and docetaxel) given alongside radiation therapy for adults with large (over 5 cm), high-grade soft tissue sarcoma of the arms or legs. The goal was to find the safest dose and see how well the body to…
Phase: PHASE1 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
No-Pill pain control: Opioid-Free approach after prostate surgery
Symptom relief TerminatedThis study tested whether a combination of non-opioid medicines (ketamine, ketorolac, and acetaminophen) can control pain after robotic prostatectomy as well as standard opioid painkillers. Men aged 40-75 with prostate cancer were randomly assigned to receive either opioids or th…
Phase: PHASE2, PHASE3 • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC
-
Short-Term nerve zap device tested for knee pain – but trial halted early
Symptom relief TerminatedThis study tested a temporary peripheral nerve stimulation system (SPRINT PNS) placed near the knee for up to 60 days to relieve chronic pain from osteoarthritis. Only 12 people were enrolled, and the trial was terminated early. Researchers measured pain intensity, quality of lif…
Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
Pain relief device for diabetic nerve pain studied, but trial stopped early
Symptom relief TerminatedThis study tested a device called BurstDR spinal cord stimulation to help people with painful diabetic neuropathy that didn't get better with standard medicines. The goal was to see if it could cut leg pain by at least half. Only 6 people joined before the study was stopped early…
Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
Tiny study on blood flow cuffs for shoulder injuries ends early
Symptom relief TerminatedThis study tested whether using a blood flow restriction (BFR) cuff during physical therapy could help people with shoulder injuries regain strength and return to activity faster. Only 3 people took part before the study was stopped early. The approach uses a special tourniquet t…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 07:56 UTC
-
Wakefulness drug shows promise for brain tumor fatigue, but study stalls
Symptom relief TerminatedThis study tested a drug called solriamfetol to see if it could safely help people with brain tumors (gliomas) feel more awake, think clearer, and have a better quality of life. Only 2 people enrolled before the study was stopped early. The main goal was to check for serious side…
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
Virtual group aims to boost resilience in young cancer survivors facing dual health threats
Symptom relief TerminatedThis study tested an online support group for young adults (ages 18-39) who had cancer treatment and were feeling anxious or distressed during the COVID-19 pandemic. The goal was to see if teaching healthy coping skills through a virtual group could improve their mood and confide…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
Web tool aims to ease tough COVID conversations
Knowledge-focused TerminatedThis study tested a web-based guide to help people have conversations about COVID-19. It enrolled 30 adults who spoke English or Spanish. The guide offered virtual conversations tailored to different concerns. The study was terminated early, so results are limited.
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:02 UTC
-
Heart pump brain risk study halted after just 6 patients
Knowledge-focused TerminatedThis study aimed to measure normal brain blood flow in people with mechanical heart pumps (like LVADs or ECMO). Researchers wanted to find target pump settings that might prevent brain injuries. However, the study was terminated early after enrolling only 6 participants, so no us…
Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:03 UTC
-
Antifungal drug tested against brain tumors – trial stopped early
Knowledge-focused TerminatedThis early-phase trial tested whether the antifungal drug ketoconazole could block a protein called tGLI1 in brain tumors. It included 15 people with breast cancer that spread to the brain or with a type of brain cancer called glioma. The study was terminated early, so we have li…
Phase: EARLY_PHASE1 • Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
Lung cancer Follow-Up study ends early – only 5 participants
Knowledge-focused TerminatedThis pilot study tested a program called SHAREDCare, where a navigator helps lung cancer survivors identify their needs and create a plan to address them. The goal was to improve follow-up care after cancer treatment. However, the study was terminated early and included only 5 pe…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC
-
Can a Stick-On sensor replace finger pricks before surgery?
Knowledge-focused TerminatedThis pilot study tested whether continuous glucose monitors (CGMs) could be used in the days before and after surgery to track blood sugar in people with diabetes. Researchers placed a CGM sensor on 22 patients during a preoperative visit and compared its readings to standard fin…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:06 UTC
-
Hernia mesh showdown: fortiva vs strattice – which works better?
Knowledge-focused TerminatedThis study compared two biologic meshes, Fortiva and Strattice, used to repair ventral hernias. Researchers planned to track hernia recurrence and mesh-related complications in patients. However, the study was terminated early and only enrolled 6 people, so no reliable conclusion…
Phase: NA • Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC
-
Can the 'Love Hormone' ease pain? small study tests oxytocin
Knowledge-focused TerminatedThis study looked at whether a single IV dose of oxytocin, a natural hormone, could reduce pain from heat on the skin. It included 7 people — some healthy and some with severe knee arthritis. Researchers measured pain scores during a 5-minute heat test. The study was terminated e…
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Knowledge-focused
Last updated Jun 26, 2026 15:39 UTC